Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

8.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.4K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

10.7K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
10.7K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

9.6K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
9.6K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.6K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

87.3K
Overview
87.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in Cells.

ACS chemical biology·2025
Same author

Orthogonal IMiD-Degron Pairs Induce Selective Protein Degradation in Cells.

bioRxiv : the preprint server for biology·2024
Same author

Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases.

European journal of haematology·2024
Same author

Advanced Cell Therapy: Beyond the last Frontier in the Treatment of Cancer. A Historical Perspective Emphasizing the Work of Nobel Prize Laureates.

Archives of medical research·2022
Same author

Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patients.

EJHaem·2022
Same author

Enumerating regulatory T cells in cryopreserved umbilical cord blood samples using FOXP3 methylation specific quantitative PCR.

PloS one·2020

Related Experiment Video

Updated: Apr 9, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

22.2K

Natural Killer Cell Immunotherapy: From Bench to Bedside.

Anna Domogala1, J Alejandro Madrigal1, Aurore Saudemont1

  • 1Anthony Nolan Research Institute , London , UK ; University College London , London , UK.

Frontiers in Immunology
|June 20, 2015
PubMed
Summary

Natural killer (NK) cell therapy shows promise for cancer treatment but faces challenges in patient persistence and expansion. Research is exploring methods to enhance NK cell production and activation for improved clinical efficacy.

Keywords:
activationcancerimmunotherapynatural killer cellspersistenceproliferation

More Related Videos

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

11.6K
Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

6.6K

Related Experiment Videos

Last Updated: Apr 9, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

22.2K
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

11.6K
Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

6.6K

Area of Science:

  • Immunology
  • Oncology
  • Cellular Therapy

Background:

  • Natural killer (NK) cells demonstrate significant in vitro potential against various malignancies.
  • Clinical application of NK cell therapy is limited by poor in vivo persistence and expansion.
  • Current strategies involve isolating NK cells from different sources or differentiating them from hematopoietic stem cells.

Purpose of the Study:

  • To review methods for obtaining and activating NK cells for clinical use.
  • To identify optimal strategies for enhancing NK cell proliferation, persistence, and function.
  • To consider ideal product and drug combinations for successful NK cell therapy.

Main Methods:

  • Review of existing literature on NK cell isolation, expansion, and activation techniques.
  • Analysis of clinical data on NK cell therapy outcomes.
  • Evaluation of adjunctive drugs and stimulation methods for NK cell enhancement.

Main Results:

  • NK cells are obtainable from peripheral blood, umbilical cord blood, or bone marrow.
  • Cytokines, drug combinations (e.g., lenalidomide, bortezomib), and priming techniques can improve NK cell function.
  • The optimal combination of methods varies by malignancy and requires further investigation.

Conclusions:

  • Effective NK cell therapy requires overcoming challenges in cell persistence and expansion.
  • Further research is needed to determine optimal methods for NK cell acquisition, activation, and combination therapies.
  • Tailoring NK cell strategies to specific malignancies is crucial for clinical success.